Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Walker

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|December 1, 1992
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenaseR M McMillan, K E Spruce, G C Crawley, et al.
The Journal of Rheumatology|February 1, 1988
The characterization of normal and scleroderma skin fibroblasts cultured in a collagen gel matrixM D Mayes, E R Walker, R G Frederickson, et al.
Prostaglandins|October 1, 1976
Synthesis and biological activity of 16, 17-configurationally-rigid-17-aryl 18,19,20-trinorprostaglandinsD G Fletcher, K H Gibson, H R Moss, et al.
Digestion|January 1, 1990
Short bowel syndromeJ M Nightingale, E R Walker, W R Burnham, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1989
Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestineJ M Nightingale, E R Walker, W R Burnham, et al.
Arthritis and Rheumatism|May 1, 1991
Morphologic and morphometric changes in synovial membrane associated with mechanically induced osteoarthrosisE R Walker, R D Boyd, D D Wu, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Hormonal regulation of the age-associated decline in immune functionK W Kelley, S Brief, H J Westly, et al.
Journal of Dentistry and Oral Hygiene|June 7, 2011
In vitro remineralization of human and bovine white-spot enamel lesions by NaF dentifrices: A pilot studyR L Karlinsey, A C Mackey, T J Walker, et al.
Gut|September 1, 1993
Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'J M Nightingale, M A Kamm, J R van der Sijp, et al.
Journal of Medicinal Chemistry|July 10, 1992
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitorsG C Crawley, R I Dowell, P N Edwards, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|December 1, 1992
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenaseR M McMillan, K E Spruce, G C Crawley, et al.
The Journal of Rheumatology|February 1, 1988
The characterization of normal and scleroderma skin fibroblasts cultured in a collagen gel matrixM D Mayes, E R Walker, R G Frederickson, et al.
Prostaglandins|October 1, 1976
Synthesis and biological activity of 16, 17-configurationally-rigid-17-aryl 18,19,20-trinorprostaglandinsD G Fletcher, K H Gibson, H R Moss, et al.
Digestion|January 1, 1990
Short bowel syndromeJ M Nightingale, E R Walker, W R Burnham, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1989
Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestineJ M Nightingale, E R Walker, W R Burnham, et al.
Arthritis and Rheumatism|May 1, 1991
Morphologic and morphometric changes in synovial membrane associated with mechanically induced osteoarthrosisE R Walker, R D Boyd, D D Wu, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Hormonal regulation of the age-associated decline in immune functionK W Kelley, S Brief, H J Westly, et al.
Journal of Dentistry and Oral Hygiene|June 7, 2011
In vitro remineralization of human and bovine white-spot enamel lesions by NaF dentifrices: A pilot studyR L Karlinsey, A C Mackey, T J Walker, et al.
Gut|September 1, 1993
Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'J M Nightingale, M A Kamm, J R van der Sijp, et al.
Journal of Medicinal Chemistry|July 10, 1992
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitorsG C Crawley, R I Dowell, P N Edwards, et al.
Pageof 5